Benefits of utilizing gene-modified iPSCs for clinical applications

James Ellis, Christopher Baum, Nissim Benvenisty, Gustavo Mostoslavsky, Hideyuki Okano, William L. Stanford, Matthew Porteus, Michel Sadelain

Research output: Contribution to journalLetter

17 Citations (Scopus)
Original languageEnglish
Pages (from-to)429-430
Number of pages2
JournalCell stem cell
Volume7
Issue number4
DOIs
Publication statusPublished - 2010 Oct 8

ASJC Scopus subject areas

  • Molecular Medicine
  • Genetics
  • Cell Biology

Cite this

Ellis, J., Baum, C., Benvenisty, N., Mostoslavsky, G., Okano, H., Stanford, W. L., Porteus, M., & Sadelain, M. (2010). Benefits of utilizing gene-modified iPSCs for clinical applications. Cell stem cell, 7(4), 429-430. https://doi.org/10.1016/j.stem.2010.09.010